Missense Variants in COL4A1/2 Are Associated with Cerebral Aneurysms: A Case Report and Literature Review
- PMID: 38392956
- PMCID: PMC10892350
- DOI: 10.3390/neurolint16010015
Missense Variants in COL4A1/2 Are Associated with Cerebral Aneurysms: A Case Report and Literature Review
Abstract
Background: Although cerebral aneurysm (CA) is a defining complication of COL4A1/2-related vasculopathy, the specific factors influencing its onset remain uncertain. This study aimed to identify and analyze these factors.
Methods: We described a family presenting with a novel variant of the COL4A1 gene complicated with CA. Concurrently, an exhaustive review of previously documented patients with COL4A1/2-related vasculopathy was conducted by sourcing data from PubMed, Web of Science, Google Scholar, and Ichushi databases. We compared the variant types and locations between patients with CA (positive group) and those without CA (negative group).
Results: This study included 53 COL4A1/2 variants from 76 patients. Except for one start codon variant, all the identified variants in CA were missense variants. Otherwise, CA was not associated with other clinical manifestations, such as small-vessel disease or other large-vessel abnormalities. A higher frequency of missense variants (95.5% vs. 58.1%, p = 0.0035) was identified in the CA-positive group.
Conclusions: CA development appears to necessitate qualitative alterations in COL4A1/2, and the underlying mechanism seems independent of small-vessel disease or other large-vessel anomalies. Our findings suggest that a meticulous evaluation of CA is necessary when missense variants in COL4A1/2 are identified.
Keywords: COL4A1; COL4A2; cerebral aneurysm; large vessel abnormality; small vessel disease.
Conflict of interest statement
Osamu Onodera received a speaker honorarium from Kyowa Hakko Kirin Co., Ltd., Bristol-Myers Squibb, Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharm, Takeda, Daiichi-Sankyo, FUJIFILM, SANOFI, and FP-pharm. Other authors have no conflicts of interest to declare.
Figures




Similar articles
-
Biallelic COLGALT1 variants are associated with cerebral small vessel disease.Ann Neurol. 2018 Dec;84(6):843-853. doi: 10.1002/ana.25367. Epub 2018 Nov 30. Ann Neurol. 2018. PMID: 30412317
-
Main features of COL4A1-COL4A2 related cerebral microangiopathies.Cereb Circ Cogn Behav. 2022 Mar 24;3:100140. doi: 10.1016/j.cccb.2022.100140. eCollection 2022. Cereb Circ Cogn Behav. 2022. PMID: 36324412 Free PMC article.
-
Impaired intracellular Ca2+ signaling contributes to age-related cerebral small vessel disease in Col4a1 mutant mice.Sci Signal. 2023 Nov 14;16(811):eadi3966. doi: 10.1126/scisignal.adi3966. Epub 2023 Nov 14. Sci Signal. 2023. PMID: 37963192 Free PMC article.
-
Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndrome.Curr Med Chem. 2010;17(13):1317-24. doi: 10.2174/092986710790936293. Curr Med Chem. 2010. PMID: 20166936 Review.
-
The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature.Genet Med. 2015 Nov;17(11):843-53. doi: 10.1038/gim.2014.210. Epub 2015 Feb 26. Genet Med. 2015. PMID: 25719457 Review.
Cited by
-
Collagen IV in Gould syndrome and Alport syndrome.Nat Rev Nephrol. 2025 Jul 31. doi: 10.1038/s41581-025-00982-x. Online ahead of print. Nat Rev Nephrol. 2025. PMID: 40745060 Review.
References
-
- Yoneda Y., Haginoya K., Arai H., Yamaoka S., Tsurusaki Y., Doi H., Miyake N., Yokochi K., Osaka H., Kato M., et al. De Novo and Inherited Mutations in COL4A2, Encoding the Type IV Collagen alpha 2 Chain Cause Porencephaly. Am. J. Hum. Genet. 2012;90:86–90. doi: 10.1016/j.ajhg.2011.11.016. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources